Two pharmaceutical companies in Danbury -- one big and one small -- are in a race to get federal approval for drugs that can reverse the effects of blood clotting agents. Boehringer Ingelheim, an international company with billions of dollars at its disposal, and local startup Perosphere, are in trials with drugs that can reserve the effects of certain anticoagulants, also known as blood thinners.
via Danbury Newswire http://ift.tt/1wljtwf
via Danbury Newswire http://ift.tt/1wljtwf
No comments:
Post a Comment